Abstract
We investigate a policy of professional incorporation in Canada which allows physicians to defer higher personal income taxes. Incorporated physicians earn income now, but can shield it from high personal taxation by retaining it within their corporation. Shielded income can then be consumed during retirement when the physician is subject to lower personal income taxes. This alters incentives for labour supply over the career life cycle. Using a difference-in-differences econometric strategy and cross-provincial variation in policy timing we compare provinces that allowed incorporation to those that did not (first difference) before and after adoption of these policies (second difference). After incorporation, we find no evidence of intensive margin improvement in physicians' supply of services or payments. Allowing incorporation modestly increases interprovincial migration and reduces emigration of physicians. However, five years post-implementation, we find a 6.8% decline in total physician supply and larger impacts among older physician cohorts, suggesting that the policy facilitated earlier retirement. Our findings highlight how these policies may have unintended long-term effects on physician supply through incentivizing retirement.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.